FDA Inspection 1254829 — Milestone Pharmaceutiques Inc.
The FDA completed an inspection of Milestone Pharmaceutiques Inc. on Nov 19, 2024 in Saint-Laurent. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 19, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint-Laurent (Canada)
Additional Details
Sponsor, Contract Research Organization
Citations
| ID | CFR | Description |
|---|---|---|
| 7557 | 21 CFR 312.56(b) | Notification of FDA of termination of investigator |